At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
Intralipid 20% +1 moredrug
Likely dose
Intralipid 20% 30 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Crossover Study to Evaluate the Effect of Lipid Infusion on TLR4 Signaling and Insulin Resistance in Human Muscle
The University of Texas Health Science Center at San Antonio·interventional·Posted Dec 4, 2012·Updated Jan 25, 2016
In Brief
A clinical study evaluating Intralipid 20% and Saline for Diabetes and Obesity. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether a lipid infusion can up-regulate toll-like receptor 4 (TLR4) signaling in human subjects
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2008
First PostedDec 2012
Primary CompletionDec 2013
Study CompletionSep 2015
TodayJul 2026
First PostedDec 4, 2012
Enrollment StartJan 1, 2008
Primary CompletionDec 1, 2013
Study CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 13.6 years ago
Interventions
Intralipid 20%drug
30 ml/h for 48 h
Salinedrug
30 ml/h for 48 h